Adar1 Capital Management, LLC Bio Atla, Inc. Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
A detailed history of Adar1 Capital Management, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 170,506 shares of BCAB stock, worth $63,087. This represents 0.01% of its overall portfolio holdings.
Number of Shares
170,506Holding current value
$63,087% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
41Shares Held
13.4MCall Options Held
20.7KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.84MShares$1.79 Million1.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$659,7640.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.49MShares$552,2440.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$508,4080.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$292,8770.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $13.4M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...